Last updated: March 2026
Testagen is a Khavinson bioregulator peptide isolated from testicular tissue extracts, developed at the St. Petersburg Institute of Bioregulation and Gerontology. It modulates gene expression associated with steroidogenesis and Leydig cell activity for male reproductive health.
Testagen belongs to the Khavinson peptide bioregulator family — short peptides (typically 2-4 amino acids) that cross cell and nuclear membranes to interact directly with DNA, modulating gene expression in specific tissue types. Testagen targets testicular tissue.
Short peptide bioregulators can cross nuclear membranes and interact with DNA, potentially modulating expression of genes involved in steroidogenesis — the pathway that produces testosterone.
Proposed to stimulate Leydig cell activity — the cells in the testes responsible for testosterone biosynthesis. May improve cellular metabolism in testicular tissue.
Research suggests potential protective effects against environmental stressors including radiation, vibration, and toxic substances that can damage testicular function.
Works through the Khavinson bioregulator model — restoring peptide pools that decline with age, potentially normalizing cellular function without replacing hormones directly.
Context: Testagen data comes primarily from the Khavinson bioregulator research program. Evidence is limited — mostly in vitro studies and animal models. No large-scale randomized controlled trials exist. The bioregulator concept is well-established in Russian medicine but not widely validated in Western science.
Self-Assessment
Dosing schedules, interaction warnings, and cycle protocols for 50+ compounds — all in one place.
Third-party tested compounds from Swiss Chems — one of the most trusted research suppliers.
Affiliate link — supports MeetPeptide at no extra cost.
Testagen is NOT FDA approved and is available only for research purposes. Evidence is limited and preliminary. This page is for educational purposes only. Not medical advice. Research Only